Navigation Links
Upsher-Smith Laboratories, Inc. Updates Prenexa.com with Folic Acid Content, Money-Saving Coupon, and Personalized Address Labels
Date:7/13/2009

Upsher-Smith announces updates to its Website, prenexa.com.

Minneapolis, MN (PRWEB) July 13, 2009 -- Upsher-Smith announces updates to its Website, www.prenexa.com. PreNexa® is the first single capsule prenatal vitamin with more plant-based DHA (docosahexaenoic acid) than other single capsule prenatal vitamins taken once a day.(1-4)

The updated content and offerings on prenexa.com include:

 
Folic acid:
Folic acid is a type of Vitamin B that the body uses to make DNA and RNA. Without enough folic acid in their diet, women are at a greater risk of giving birth to infants with neural tube defects. For more information about folic acid and PreNexa®, visit prenexa.com.

$5 money-saving coupon:
A PreNexa® coupon is now available at prenexa.com. Throughout 2009, consumers can save $5 on each PreNexa® prescription by simply downloading the coupon and redeeming it at their pharmacy. Visit prenexa.com to download a $5 coupon.

Personalized address labels:
Now it's possible for visitors to personalize, download, and print address labels at prenexa.com. With 9 different designs to choose from, visitors can add a bit of flair to their envelopes or use the labels as colorful gift tags. Find out more at prenexa.com.

Important Safety Information:
Please see full Prescribing Information for a complete list of warnings and precautions.

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep This Product Out Of The Reach Of Children. In case of accidental overdose, call a doctor or poison control center immediately.

About Upsher-Smith Laboratories:
Upsher-Smith Laboratories is an established and rapidly growing pharmaceutical company that manufactures and markets both prescription and consumer products. Privately held since 1919, the company strives to recognize the unmet healthcare needs of our customers. Upsher-Smith prides itself in providing safe, effective, and economical therapies to the ever-challenged healthcare environment. For additional information about Upsher-Smith, visit upsher-smith.com.

References:
1. PreNexa package insert. Minneapolis, MN: Upsher-Smith Laboratories, Inc; 2008.
2. Prenate DHA package insert. Atlanta, GA: Sciele Pharma, Inc; 2007.
3. PrimaCare One package insert. St Louis, MO: Ther-Rx Corporation; 2007.
4. Neevo DHA package insert. Covington, LA: Pamlab, LLC; 2009.

103428.01

###

Read the full story at http://www.prweb.com/releases/prenexa/prenatal-vitamins/prweb2630654.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Upsher-Smith Laboratories Launches Prenexa.com to Support Prenatal Nutrition and Health
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
5. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2008 Second Quarter Earnings
6. Roxane Laboratories, Inc. Announces the Launch of Oxcarbazepine Tablets, 150mg, 300mg and 600mg
7. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
8. Getting Ready Corporation and Winston Laboratories, Inc. Announce Merger Agreement
9. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
11. Bond Laboratories, Inc. Announces 2-for-1 Forward Split
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Upsher-Smith Laboratories, Inc. Updates Prenexa.com with Folic Acid Content, Money-Saving Coupon, and Personalized Address Labels
(Date:2/24/2017)... ... February 24, 2017 , ... ... tooth replacement options at his office, Antoine Dental Center. Currently, patients can get ... Some restrictions may apply, but patients can learn more about these offers by ...
(Date:2/24/2017)... ... , ... An in-depth computational analysis of genetic variants implicated in both schizophrenia ... that may explain why susceptibility to one of the disorders could place individuals at ... in the journal npj Schizophrenia. , “There is a wealth of genomic data ...
(Date:2/24/2017)... NY (PRWEB) , ... February 24, 2017 , ... In ... needs to be a top priority because it’s not if you will be attacked, ... safety, especially when it comes to digital health care. , Improvements in auditing and ...
(Date:2/24/2017)... ... February 24, 2017 , ... The narrative in “ Signal 8: An Australian ... account of his paramedic experiences. Schanssema describes the tragedies he saw, as well as ... overcome them. , Schanssema, initially unsure of the career path he wanted to take, ...
(Date:2/24/2017)... , ... February 24, 2017 , ... Yisrayl Hawkins, Pastor ... on Bible Prophecy concerning this present generation. Yisrayl makes an astounding statement when ... generation. He explains that the Bible details the current times so plainly that ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 23, 2017 Report analyzes the worldwide ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... are provided for the period 2015 through 2022. Also, a ... and analytics are derived from primary and secondary research. Company ...
(Date:2/24/2017)... , Feb. 23, 2017  This report analyzes ... by the following Products: Intermediates, Analytical, ... the report include Pharmaceuticals, and Agrochemicals. The report provides ... , Europe , and Rest ... the period 2015 through 2022. Also, a six-year historic ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
Breaking Medicine Technology: